Invention Grant
- Patent Title: Use of anti-FAM19A5 antibodies for treating atherosclerosis
-
Application No.: US17418681Application Date: 2019-12-26
-
Publication No.: US12247070B2Publication Date: 2025-03-11
- Inventor: Bongcheol Kim , Dong Sik Kim , Jae-Keun Lee , Juwon Shim
- Applicant: NEURACLE SCIENCE CO., LTD.
- Applicant Address: KR Seoul
- Assignee: NEURACLE SCIENCE CO., LTD.
- Current Assignee: NEURACLE SCIENCE CO., LTD.
- Current Assignee Address: KR Seoul
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- International Application: PCT/IB2019/061377 WO 20191226
- International Announcement: WO2020/136603 WO 20200702
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61P9/10 ; A61K39/00
Abstract:
The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat an atherosclerosis in a subject in need thereof.
Public/Granted literature
- US20220064277A1 USE OF ANTI-FAM19A5 ANTIBODIES FOR TREATING ATHEROSCLEROSIS Public/Granted day:2022-03-03
Information query
